Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Nebilet

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: Nebivolol is a potent third generation beta-blocking agent indicated for the treatment of hypertension, and is… Expand
  • table 2
  • table 3
  • table 10
  • table 13
  • figure 1
Is this relevant?
2012
2012
There were investigated 22 patients with chronic obstructive pulmonary disease in association with arterial hypertension… Expand
Is this relevant?
2009
2009
Endothelial dysfunction, which is characterized by impairment of nitric oxide (NO) bioavailability, plays an important role in… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2009
2009
Objective: The aim of this study is to evaluate the effects of the treatment with the angiotensin receptor blocker - Diovan and… Expand
Is this relevant?
2006
2006
The study was aimed to assess influence of nebivolol (nebilet) on endothelial factors (NO and endothelin1) during treatment of… Expand
Is this relevant?
2006
2006
We report results of our prospective study - administration of Nebilet in 30 patients in perioperative period. Aim of this study… Expand
Is this relevant?
2005
2005
ObjectiveTo examine the economic consequences of effective antihypertensive treatment using the novel vasodilating β1… Expand
Is this relevant?
2001
2001
UNLABELLED Twenty-four patients with bronchial hyperreactivity due to asthma (8 patients), COPD (13) and of unknown origin (3… Expand
Is this relevant?
2001
2001
Twenty-four patients with bronchial hyperreactivity due to asthma (8 patients), COPD (13) and of unknown origin (3) entered and… Expand
Is this relevant?